The human pulmonary surfactant protein A (hSP-A) has been implicated in the early capture and phagocytosis of the pathogenic Mycobacterium tuberculosis by alveolar macrophages. In this report, we examined the interaction of alveolar proteinosis patient hSP-A with Mycobacterium bovis BCG, the vaccinating strain, as a model of pathogenic mycobacteria, and Mycobacterium smegmatis, a nonpathogenic strain. We found that hSP-A binds to the surface of M. bovis BCG, but also to a slightly lesser extent, to M. smegmatis, indicating that hSP-A does not discriminate between virulent and nonpathogenic strains. Among the various glycoconjugates isolated from the mycobacterial envelope, we found that the best ligands are the two major lipoglycans: the mannosylated lipoarabinomannan (ManLAM) and the lipomannan. In contrast, the mannose-capped arabinomannan, structurally close to the ManLAM, as well as the LAMs from the non pathogenic M. smegmatis are poorly recognized by hSP-A. These results clearly show that the presence of both the terminal mannose residues and the phophatidyl-myo-inositol anchor are necessary to achieve the highest binding affinity. Selective removal of either the terminal mannose or the acyl residues esterifying the glycerol moiety of the ManLAM abrogates the interaction with hSP-A, further supporting the notion that the hSP-A recognition of the carbohydrate epitopes of the lipoglycans is dependent of the presence of the fatty acids.
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were found to interact with M. tuberculosis. However, despite their great structural analogy, they have opposite effects toward the phagocytosis of invading mycobacteria. Whereas hSP-D seems to reduce the uptake of pathogenic bacilli by macrophages (6), hSP-A was shown to promote the attachment of M. tuberculosis to phagocytes (7) , suggesting a new way for the pathogenic bacillus to gain access to its target cell. Moreover, further elucidation of the effect of hSP-A shows that this protein may have different roles. Direct interaction between hSP-A and phagocytes leads to the up-regulation of the macrophage mannose receptor that is responsible for the increase in M. tuberculosis uptake (8) . On the other hand, Weikert et al. (9) reported that hSP-A may also act as an opsonin, enhancing the phagocytosis of Mycobacterium bovis BCG by macrophages. This result suggests that opsonization mechanisms leading to the phagocytosis of invading pathogenic mycobacteria may occur in the alveolar space, just following the initial inoculation, despite the low concentration of soluble serum complement opsonins.
Because of the major importance of these processes in the capture of the airborne pathogenic mycobacteria and their transfer across the pulmonary surfactant toward their target cells, we focused our attention on the opsonizing role of hSP-A. In their study, Weikert et al. (9) demonstrate that phagocytosis of hSP-A coated M. bovis BCG results from the binding of the collagen-like domain of hSP-A to a specific phagocyte surface receptor (SPR210). Moreover the interaction of hSP-A with mycobacteria was shown to be calcium and carbohydrate-dependent, suggesting that the binding is mediated by the lectin domains of hSP-A. However, the identity of the mycobacterial ligand(s) to which hSP-A binds remains to be defined.
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‡ To whom correspondence should be addressed: IPBS CNRS, 205 route de Narbonne, 31077 Toulouse cedex, France. Tel.: 33-5-61-17-55-58; Fax: 33-5-61-17-59-94; E-mail: riviere@ipbs.fr. mannan (ManLAM) are already identified as possible mediators of the adhesion of the mycobacteria to the phagocyte by binding to the serum mannose-binding protein (10) , the macrophage CR3 (11) , and the mannose receptor (12) , respectively. More recently, ManLAM was also shown to be the predominant ligand of SP-D (6) .
The goal of the present report was 1) to examine whether hSP-A discriminates pathogenic (M. bovis BCG) from nonpathogenic (Mycobacterium smegmatis) mycobacteria, 2) to identify the putative mycobacterial surface glycoconjugates which may serve for hSP-A attachment, and 3) to determine the ligand structural motifs mediating the interaction. Our results demonstrate that hSP-A opsonization is not restricted to pathogenic mycobacteria and may be mediated by major lipoglycans found in the mycobacterial envelope. Moreover, the observations reported here highlight that the lipidic components of the ligand are required for the recognition of the carbohydrate epitopes by hSP-A. 155 were cultured as pellicles on SAUTON medium. After removal of the medium, cells used for solid phase binding assays were desegregated by treatment with glass beads (3-mm diameter) and washed three times in coating buffer (15 mM Na 2 CO 3 , 35 mM NaHCO 3 , pH 9.5, 1% sodium deoxycholate).
EXPERIMENTAL PROCEDURES

Materials
Preparation of Mycobacterial Cell Wall Glycoconjugates-"Cellular" and "parietal" LAMs from M. smegmatis mc 2 155, M. bovis BCG 1173P2, and M. tuberculosis H37Rv were purified in our laboratory as described previously (13, 14) Preparation of Deacylated LAM (dManLAM)-M. bovis BCG cellular ManLAM (200 g) was incubated (2 h) at 37°C in NaOH 0.1 N (final volume 200 l). After neutralization with HCl, the reaction product was dialyzed with 6000-8000 molecular weight cutoff membranes (spectra/ por®, Spectrum Medical Industries, Inc., Houston, TX) against deionized water.
Preparation of ␣-Mannosidase-treated LAM (aManLAM)-M. bovis BCG cellular ManLAM (200 g) was incubated (6 h) at 37°C in 30 l of ␣-mannosidase from jack bean (2 mg/ml, 100 mM Na 2 CO 3 , pH 4.5, 1 mM ZnSO 4 ). After a second addition of 50 l of enzyme, the solution was incubated overnight, then dialyzed against 50 mM NH 4 CO 3 , pH 7.6. Elimination of ␣-mannosidase was achieved by denaturation (2 min, 110°C) followed by overnight tryptic digestion (37°C, trypsin/␣-mannosidase ratio ϭ 2% by weight). After extensive dialysis against deionized water, the reaction products were analyzed by capillary zone electrophoresis as described previously (13) .
Purification of hSP-A-hSP-A was purified from bronchoalveolar lavage fluid (BALF) from patients with alveolar proteinosis (15) with some modifications. Briefly, alveolar surfactant was isolated from 150 ml of BALF by centrifugation (20,000 ϫ g, 4°C, overnight). The pellet was delipidated by extraction with 100 ml of n-butyl alcohol. After centrifugation (5000 ϫ g, 4°C, 30 min), the pellet, containing n-butyl alcohol insoluble proteins, was dried under a gentle stream of nitrogen. The resulting powder was suspended in 50 ml of 5 mM Tris-HCl, pH 7.4, 100 mM NaCl, 20 mM n-octyl glucoside to solubilize serum proteins. hSP-A and others insoluble proteins were collected by ultracentrifugation (200,000 ϫ g, 4°C, 30 min). The pellet was washed twice in the same buffer and then suspended in 5 ml of 5 mM Tris-HCl, pH 7.4. Elimination of the residual n-octyl glucoside was achieved by extensive dialysis against the same buffer. Insoluble material was removed by centrifugation (100,000 ϫ g, 20°C, 30 min) and the supernatant containing hSP-A was frozen in small aliquots.
Solid Phase Binding Assays-Solid phase binding assays were carried out on microtiter plates (Nunc-Immuno, Nalge Nunc International, Rochester, NY To examined the ability of hSP-A contained in BALF to bind to mycobacterial cells, 10 7 cells in 100 l of coating buffer were adsorbed in the microtiter wells by incubation for 1 h at 37°C. After extensive washing with washing buffer without Tween 20, the wells were blocked for 2 h with blocking buffer before addition of 100 l of hSP-A solution (60 g/ml) or BALF adjusted to 1 mM CaCl 2 and 0.4% low fat dry milk. Subsequent steps were the same as described above except that the dilutions of primary and secondary antibodies and all steps of washing were performed in washing buffer without Tween 20.
Quantification of the amount of ligand bound to the microtiter wells was performed as described previously (6) using the DIG-Glycan Detection Kit (Roche Molecular Biochemicals, Mannheim, Germany).
Competition Assays-Monosaccharide competition studies were carried out on microtiter plates. Microtiter wells were coated with 50 l of M. bovis BCG cellular ManLAM (10 g/ml in EtOH/H 2 O 1:1) by air drying at 37°C. Wells were incubated 2 h with blocking buffer and then extensively rinsed with washing buffer. 100 l of hSP-A (15 g/ml) plus competitors (0 -100 mM in washing buffer) were added and allowed to react overnight with coated M. bovis BCG cellular ManLAM. Bound hSP-A was detected as described above.
Competition assays using mycobacterial glycoconjugates as competitors were performed as above at 5 and 50 g/ml in hSP-A solutions.
Data Analysis-The number of maximum binding sites and the equilibrium dissociation constants for hSP-A/M. bovis BCG cellular Man-LAM or mycobacterial cells were determined by fitting experimental results with either one or two site binding hyperbola using Graph Pad Prism® (GraphPad Software Inc., San Diego, CA).
The IC 50 for the different competitors was graphically determined as the competitor concentration resulting in 50% of inhibition. The need for calcium strongly suggests that hSP-A binding to mycobacteria is specifically mediated by the carbohydrate recognition domains. However, as noticed by several others workers (9, 16, 17), we observed a very limited inhibitory effect of monosaccharides (mannose, glucose, galactose) at concentrations up to 100 mM (data not shown). In a same way, the addition of multivalent ligands such as Saccharomyces cerevisiae mannan or mannosylated bovine serum albumin (up to 1 mg/ml) does not affect significantly the binding of hSP-A to mycobacteria. Although others report some inhibition using mannosylated bovine serum albumin at 10 mg/ml (16, 17) , such high protein concentration may affect the interaction nonspecifically.
RESULTS
hSP-A Binding to Mycobacterial Cells-To
In their study, Weikert et al. (9) reported that hSP-A may act as an opsonin, enhancing the phagocytosis of M. bovis BCG by macrophages. This result suggests that opsonization mechanisms leading to the phagocytosis of invading mycobacteria may occur in the alveolar space, just following the initial inoculation. Because in the alveolar surfactant, hSP-A is associated with phospholipids, we examined the ability of hSP-A contained in BALF to bind to mycobacterial cells. As shown by Interaction of hSP-A with Purified Mycobacterial Envelope Glycoconjugates-To identify the mycobacterial surface determinants involved in the binding, the most abundant glycoconjugates associated with the envelope were tested by a solid phase binding assay.
In a previous study, Weikert et al. have postulated that the arabinogalactan could be a ligand for hSP-A (9). However, in the present work we found that purified arabinogalactan (AG), obtained after alkali treatment of mycobacterial cell wall (18) , failed to interact with hSP-A in the solid phase assay (Fig. 3) . This result is consistent with the previous carbohydrate affinity studies showing that hSP-A binds to mannose and glucose, but not to galactose (19) . From this observation we expected that hSP-A should interact with any glycoconjugates containing terminal mannose or glucose residues. However the S. cerevisiae mannan or the glucan (GL), one of the most abundant glycogen-like polysaccharidic components of the mycobacterial external capsule (20) , were found to interact poorly with hSP-A at the concentrations tested in solid phase assay (Fig. 3) . In the same way, the M. bovis BCG arabinomannan (ManAM), which shares with the ManLAM the same mannose-capped polysaccharidic backbone, is poorly recognized by hSP-A. Surprisingly, the PIMs, recently identified as predominant ligand of the mannose-binding protein (10) , were also found to react very slightly with hSP-A despite the presence of terminal ␣-mannosyl residues. Finally, as suspected from previous observations (22) the cellular mannose-capped lipoarabinomannan (cManLAM) isolated from M. bovis BCG was found to strongly interact with hSP-A. However, more surprisingly, hSP-A binds also to the mycobacterial lipomannan (LM), which is devoid of mannose caps. Similar experiments performed with the crude BALF confirm that the specificity of hSP-A binding to the lipoglycans is not affected by the presence of the other surfactant components and in particular by the endogenous phospholipids (data not shown).
To verify whether the lack of interaction with the mycobacterial polysaccharides do not results from differences in the amount of coated materials, the quantity of each adsorbed ligand was estimated by the digoxigenin-glycan assay. As shown in Table I , the adsorption was found similar for all the compounds except for the AG and GL, which display higher responses, indicating higher amount of adsorbed material.
These results demonstrate that, among the different major glycoconjugates of the mycobacterial cell wall, both ManLAM and LM are likely to be the predominant target molecules for the attachment of the pulmonary collectin to the surface of mycobacteria in the alveolar airspace.
Carbohydrate Specificity of the Interaction-The specificity of hSP-A binding to M. bovis BCG lipoglycans was assessed by the solid phase binding assay using cellular ManLAM as a model ligand. The results shown in Fig. 4 demonstrate that, in presence of calcium, hSP-A exhibits a dose-dependent binding to the ManLAM. Compared with the background, the addition of EDTA completely abolished the binding, indicating that the interaction is exclusively through a calcium-dependent mechanism.
Optimum binding was obtained with 100 ng of coated Man-LAM/well. In these conditions, the saturation threshold is reached with an hSP-A concentration of 40 -50 g/ml, consistent with previous work (23) . The fit of the experimental data with a single binding site model curve gives an apparent equilibrium dissociation constant K d of 8 ϫ 10 Ϫ9 M, close to the value obtained with cells.
The carbohydrate binding characteristics were determined by competitive inhibition using various monosaccharides (Fig.  5) . Among the free monosaccharides tested, D-mannose was found to be the most efficient competitor with an IC 50 (inhibitor concentration that reduces the binding by 50%) of 20 mM (3.8 g/liter). D-Glucose, but also surprisingly D-arabinose, inhibit efficiently the binding of hSP-A to ManLAM (IC 50 : 66 and 58 mM, respectively). In contrast, L-arabinose and D-galactose (as observed previously (19) ) have no inhibitory activity.
The inhibition by D-arabinose, but not by the L-isomer, strongly suggested that hSP-A may bind to the ManLAM arabinan domain exclusively constituted of D-arabinofuranosyl residues. Indeed, at equilibrium, arabinose in solution adopts the pyranoid but also, to a lesser extent, the furanoid conformation present in ManLAM. Then, to identify the arabinose form responsible for the inhibition, we performed further competition experiments with various methyl arabinosides corresponding to the different conformations adopted by the free monosaccharide in solution. Unexpectedly, the methyl arabinofuranoside (Me-␣-D-Araf) was unable to inhibit the interaction, clearly showing that hSP-A do not bind to the arabinan chains of ManLAM (Fig. 6) . In contrast, the methyl arabinopyranoside (Me-␤-D-Arap) effectively competes for the binding of hSP-A to ManLAM. This result demonstrates that the inhibition is due to the energetically favored 1 C 4 chair pyranoid conformation. Indeed, in this conformation, the hydroxyl of the D-Arap ring carbons 2 and 3 are both equatorial and display the same relative spatial arrangement than that of C3 and C4 hydroxyl groups of D-Manp or D-Glcp (Fig. 6) . Thus, by analogy with mannose-binding protein carbohydrate binding scheme (24) 
TABLE I
Glycoconjugates adsorption to microtiter plates Glycoconjugates (100 ng/50 l EtOH/H 2 3-O-1:1) were adsorbed in the microtiter wells by air drying at 37°C and incubated with sodium metaperiodate followed by digoxigenin 3-O-succinyl-⑀-amidocaproic acid hydrazide. After blocking, the wells were then incubated with alkaline phosphatase-conjugated anti-digoxigenin immunoglobulins and developed paranitrophenylphosphate. ScMan, S. cerevisiae mannan; PILAM, phosphoinositol-capped LAM; PIGAM, phosphoinositolcapped glycero-AM. Thus, these data confirm that the interaction of hSP-A with the ManLAM results from the binding of the hSP-A lectin domains to terminal mannosyl residues of this complex lipoglycan.
hSP-A Binding to Pathogenic and Nonpathogenic Mycobacterial Lipoglycans-From a structural point of view both LM and LAM (of any type) share a similar linear mannan segment constituted of an ␣136-linked mannopyranosyl backbone decorated with branched ␣132 terminal mannopyranosyl units. The main difference between LM and LAMs result from the substitution of the LAM mannan core by an additional arabinan domain. The similar level of binding observed with the ManLAM and the LM suggests that the hSP-A carbohydrate recognition domains interact with the common structure shared by these two compounds: the mannan core. To verify this assumption, we tested the hSP-A binding to the phosphoinositol-capped LAMs produced by M. smegmatis, which bears phosphoinositol caps in place of the mannose caps (14) . As shown by Fig. 7 , either the cellular phospoinositol-capped LAM or the parietal PIGAM (which differs from the phospoinositolcapped LAM by the absence of fatty acids on the glycerol moiety) do not interact significantly with the hSP-A. This observation indicates that mannan core present in LAMs does not mediate the interaction, probably due to the presence of the arabinan domain, which may mask and prevent this mannan region from serving as a ligand for hSP-A. It is then obvious that the hSP-A binding to ManLAM or LM, although arising from the same mechanisms, results from the recognition of distinct residues. Whereas interaction with the LM must be through the ␣132 mannosyl ramification of the mannan region, it is likely that mannose caps located at the extremities of the arabinan domain constitute the main epitopes recognized by hSP-A in ManLAM.
In a recent study regarding the mannose receptor-mediated uptake of ManLAMs by phagocytes, Schlesinger et al. (25) noted differences in the level of uptake between ManLAMs isolated from virulent or attenuated strains of M. tuberculosis. However, this observation could not be related to any detectable structural differences between these molecules. Using new purification strategies developed in our group, we were able to demonstrate that M. bovis BCG ManLAMs can be divided in two subpopulations, arbitrary termed parietal and cellular, which mainly differ by their acylation degree (13) . A similar approach was applied to the ManLAMs of the H37Rv virulent M. tuberculosis, and we compared their behavior toward hSP-A binding. Fig. 7 shows that the highest level of binding is achieved with the M. bovis BCG cellular ManLAM and both cellular and parietal ManLAMs from M. tuberculosis H37Rv. In contrast, the M. bovis BCG parietal ManLAM shows an intermediate level of hSP-A binding. Because it has been shown that there is no differences in the degree of mannose capping of these ManLAMs (13), we hypothesized that the lower binding may result from the specific structure of the aglycone moiety of this compound, which contains a single fatty acid in place of the two to three found in the others ManLAMs (13) . The adsorption of the different LAMs to the plates was controlled by the digoxigeninglycan assay. As shown in Table I , the adsorption is equivalent for all the LAMs tested.
In conclusion, these observations tend to indicate that hSP-A binds through its carbohydrate recognition domains to the mannose caps of ManLAMs. However, the interaction seems to be dependent on the presence of fatty acids. 
Definition of the ManLAM Structural Motifs Involved in the
Interaction-To further define the ManLAM structural motifs involved in the interaction with hSP-A, the M. bovis BCG ManLAM was first enzymatically digested by an ␣-exomannosidase. The resulting lipoglycan was hydrolyzed in mild conditions to specifically degrade the arabinan domain and the products were derivatized with fluorescent amino pyrene trisulfonate for subsequent laser-induced fluorescent detection (13) . Quantitative analysis by capillary zone electrophoresis (Fig. 8A) shows that this treatment leads to a significant loss (ϳ83%) of the manno-oligosaccharide caps (Fig. 8B) . As suspected, the solid phase binding assay with the ␣-mannosidasetreated ManLAM reveals that the removal of most of the terminal mannose residues almost completely abolished the binding (Fig. 9A) . This result definitively proves the predominant role of the mannose caps in the interaction with hSP-A.
To confirm that the fatty acids are required for the binding of hSP-A, the cellular ManLAM was submitted to alkali hydrolysis to remove the acyl substituents from the anchor. The ability of the molecule to still adhere to the plastic support was assessed by solid phase assay using polyclonal anti M. bovis BCG antibodies. The dManLAM gave a slightly lower response than the ManLAM indicating that the loss of fatty acids does not affect significantly the coating of the deacylated molecule (Fig. 8 C ) . In the same way, capillary zone electrophoresis analysis demonstrates that the deacylation treatment did not alter the amount of mannose caps of the dManLAM (Fig. 8B) . However, from Fig. 9A , it is obvious that the loss of the fatty acids results in a dramatic decrease of the level of hSP-A binding. This result is consistent with the negligible level of hSP-A binding to the ManAM despite the presence of the mannose caps. This also supports the assumption that the lower binding of hSP-A to the M. bovis BCG parietal ManLAM results from its low degree of acylation.
We then wanted to verify whether the effect of the fatty acids arises from the presentation of the ligand adsorbed on a plastic support. We tested different ligands in solution for their ability to inhibit the binding of hSP-A to ManLAM. As shown in Fig.  9B , preincubation of hSP-A with as low as 5 g/ml soluble ManLAM is sufficient to inhibit up to 80% the hSP-A binding to solid phase coated ManLAM. This value, consistent with a homogeneous distribution of hSP-A between soluble and coated ManLAM molecules, indicates that the presentation mode does not significantly affect the interaction. The LM is also found to exert a significant inhibition confirming that the terminal mannose residues of the mannan core are able to interact with hSP-A. However, it is likely that LM is less active than Man-LAM in inhibiting the interaction (IC 50 ϳ 35 g/ml). This difference in activity of LM in the solid phase assay and in solution was tentatively attributed to its lower solubility. Finally, consistent with the results obtained in the solid phase assay, both the ␣-mannosidase-treated ManLAM and the Man-AM were found to interact poorly with hSP-A confirming that the binding to the terminal mannose is dependent of the presence of the fatty acids.
DISCUSSION
To verify whether hSP-A opsonization is specific for the virulent mycobacteria thus contributing to their pathogenicity, we compared the hSP-A binding to the pathogenic M. bovis BCG and to the nonvirulent M. smegmatis. We found that hSP-A binds to M. bovis BCG in a concentration and calciumdependent manner as reported previously (9) . We estimated at 7. . hSP-A concentration: white bars, 5 g/ml; gray bars, 50 g/ml. B, competitive inhibition of cManLAM/hSP-A interaction with ␣-mannosidase-treated ManLAM (aManLAM) and naturally occurring mycobacterial LM and ManAM. Experiment was performed using two competitor concentrations: 50 g/ml (white bars) or 5 g/ml (gray bars). Values are the mean Ϯ S.E. of three experiments performed in duplicates (n ϭ 6).
order than those observed with the pathogenic strains. These results, obtained in vitro, clearly demonstrates that hSP-A does not discriminate between virulent and nonpathogenic strains, suggesting that in vivo hSP-A opsonization is probably not restricted to the pathogenic mycobacteria.
Based on the structure and properties of hSP-A defined by numerous previous studies, the need for calcium supports that the binding of hSP-A to mycobacteria may result from the recognition of mycobacterial surface carbohydrate by hSP-A lectin domains. However, like others, we found that the interaction with mycobacterial cells could not be efficiently inhibited by monosaccharides nor by S. cerevisiae mannan, mannosylated bovine serum albumin, or purified mycobacterial envelope glycoconjugates (data not shown). This point still remains unclear and suggests that mechanisms other than simple carbohydrate-lectin interactions are probably involved.
Among the purified mycobacterial envelope glycoconjugates tested in the present report, we show that hSP-A only binds strongly to the two major mannosylated lipoglycans: the Man-LAM and the LM. Whereas ManLAM is restricted to the virulent mycobacteria, the LM is ubiquitously found in the mycobacterial genus and thus may account for the binding of hSP-A to both pathogenic and nonpathogenic strains as M. smegmatis.
The binding of hSP-A to lipoglycans was calcium-and mannose-dependent. We showed that the mannose caps of the arabinan domain constitute the exclusive carbohydrate epitopes of the ManLAM, whereas the interaction with the LM seems to involve the terminal mannosyl units branched on the linear mannan segment. Moreover, we also demonstrate that the recognition and the binding of the hSP-A lectin domains to the mannose caps of the ManLAM are dependent on the presence of the fatty acids on the mannosylphosphatidylinositol anchor. This essential role of the fatty acids may account for the lack of interaction between hSP-A and ManAM whose structure differs from that of ManLAM only by the absence of the phosphatidyl anchor. Moreover, because no biological activity has been associated to ManAM despite its great structural homology to ManLAM, it has been suspected that the acyl residues are involved in most of the ManLAM properties.
Indeed, the need for the acyl residues to maintain the functional integrity of the ManLAM has been previously put forward to explain the lack of interaction of dManLAM with host immune cells (26, 27) as well as its inability to modulate the phagocyte cytokine production (13, 28, 29) . However, the complex cellular systems used in these studies do not allow a more precise definition of the functions of the lipids.
The first convincing arguments came from the recent work concerning the CD1-restricted activation of double negative CD4 Ϫ , CD8 Ϫ T-lymphocytes by mycobacterial lipoglycans (27) . Ernst et al. (30) demonstrated that the binding of the ManLAM to the CD1b antigen-presenting molecule involves hydrophobic interactions. Then they proposed that the ManLAM acyl residues must be loaded into the hydrophobic grove of the CD1 (31) and may be responsible for the high affinity cohesion of the complex.
Similar rationalization of the involvement and the role of the fatty acids in the interaction of lipoglycans with host defense lectins is more difficult. However, both hSP-A and hSP-D surfactant proteins are known to interact with lipids and to mediate phospholipid vesicles aggregation. From the numerous studies focused on the elucidation of the lipid binding sites of collectins, two main mechanisms of interaction emerge, involving different domains of the proteins. On one hand the collagenlike region of hSP-A, particularly the "neck" segment flanking the carbohydrate recognition domain, was involved in the lipid binding (32) . This neck domain (about 35 residues) constituted by an amphipathic ␣-helix followed by a short stretch of hydrophobic residues is suspected to mediate phospholipid binding and vesicle aggregation through hydrophobic interactions. The lack of inhibitory effect of the mannan on the binding of hSP-A to the lipid A moiety of bacterial lipopolysaccharide (23) strongly supports the notion that lipids interact with a site distinct from the carbohydrate-binding domain. On the other hand, site-directed mutagenesis of rat SP-A amino acids involved in the interaction with carbohydrate (E195A and R197H) were shown to also affect the interaction with phospholipids, suggesting that the carbohydrate recognition domain is intimately associated with the lipid binding properties of the collectin (33, 34) . From this and other's data obtained with recombinant SP-D (35) or chimeras of hSP-A/SP-D (36), it is likely that both domains are involved in the interaction of pulmonary collectins with lipids, but the precise mechanism of binding remains unclear.
Thus, it is suspected that the lipidic moiety of the ManLAM ensures the anchoring of the ligand to the collectin, allowing the carbohydrates to interact with the lectin domains. Indeed, it must be kept in mind that the hSP-A is composed of 18 very tightly packed carbohydrate recognition domains (37) . Thus, the binding of the acyl residues to the neck region of a trimer or to a subunit lectin domain of hSP-A may further the interaction of the mannose caps with the other carbohydrate binding sites of the protein. Furthermore, it cannot be excluded that the interaction of the fatty acids with the protein may induce some conformational changes of hSP-A enhancing the affinity for the terminal mannose residues of the lipoglycan.
In contrast, the role of the lipids may also be attributed to their functions in providing an efficient presentation of the carbohydrate epitopes. Indeed, the amphipathic nature of lipoglycans conferred by the presence of the hydrophobic phosphatidylinositol moiety may lead, in aqueous milieu, to the formation of aggregates or higher ordered assemblies as spherical, vesicular, or lamellar structures. Consequently, the huge increase in valency resulting from ligand clustering must allow multiple binding events, which may account for the selectivity and the high affinity (dissociation constant in the nanomolar range) of the interactions between hSP-A and mycobacterial lipoglycans.
Evidence of such assembly processes has been recently provided by the 31 P NMR study of both ManLAM and LM in water (38, 39) . Although much more diluted than in NMR studies, it cannot be excluded that the particular chemical architecture of these lipoglycans still promotes precise molecular assembly at concentrations below 0.3 M (lowest concentration of ManLAM used in the competitive inhibition experiment). However, to explain the consistency of the results, we must assume that the solid phase presentation also conserves and/or strictly mimics the characteristics of the ligand organization in aqueous medium. Consequently, this supposes that the organization state of the lipoglycans in solution affects their adsorption (coating) on solid supports and thereby the availability, the accessibility, and the geometry of the epitopic carbohydrate determinants.
In summary, the importance of the fatty acids can be explained either by their ability to interact directly with hSP-A or by their propensity to mediate the clustering of the ligand. Both kinds of mechanisms are known to constitute determinant processes responsible of the high specificity and the exquisite selectivity of lectin-nonself carbohydrate recognition (40) .
From our results and those of others (13, 30) , a new concept emerges regarding the function of the lipidic moiety of the mycobacterial lipoglycans. Indeed, it can be reasonably proposed that the metabolic control of the acylation state of these lipoglycans constitutes, for the mycobacteria, a way to fine tune their activities according their host microenvironment. One such regulatory system has been described for Salmonellae, which consists in alteration of the fatty acid content of the LPS lipid A moiety in response to environmental factors (21) . In this regard, the higher acylation degree of the strictly pathogenic M. tuberculosis parietal ManLAM (compared with the low virulent M. bovis BCG's one) could be considered as an advantage for the invasion of the phagocyte through hSP-A opsonization or mannose receptor mediated internalization as previously suggested (12, 22) .
